Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 03/23/2018. Reported reason: Delay in shipping of the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-162-01
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)
- Initial Posting
- 03/23/2018
- Revised Date
Reason
Delay in shipping of the drug